HK1107360A1 - Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal - Google Patents
Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammalInfo
- Publication number
- HK1107360A1 HK1107360A1 HK08101248.0A HK08101248A HK1107360A1 HK 1107360 A1 HK1107360 A1 HK 1107360A1 HK 08101248 A HK08101248 A HK 08101248A HK 1107360 A1 HK1107360 A1 HK 1107360A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- kit
- antitumoral
- mammal
- implementing
- antiviral treatment
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 230000000840 anti-viral effect Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04360101 | 2004-11-08 | ||
| US64659505P | 2005-01-26 | 2005-01-26 | |
| PCT/IB2005/003435 WO2006048768A2 (en) | 2004-11-08 | 2005-10-26 | Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1107360A1 true HK1107360A1 (en) | 2008-04-03 |
Family
ID=35539415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08101248.0A HK1107360A1 (en) | 2004-11-08 | 2005-10-26 | Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8470591B2 (zh) |
| EP (1) | EP1814907B1 (zh) |
| JP (2) | JP5372374B2 (zh) |
| KR (1) | KR101134185B1 (zh) |
| CN (1) | CN101072792B (zh) |
| AT (1) | ATE421534T1 (zh) |
| AU (1) | AU2005300248B2 (zh) |
| CA (1) | CA2584681C (zh) |
| CY (1) | CY1109850T1 (zh) |
| DE (1) | DE602005012535D1 (zh) |
| DK (1) | DK1814907T3 (zh) |
| ES (1) | ES2320157T3 (zh) |
| HK (1) | HK1107360A1 (zh) |
| IL (1) | IL183015A (zh) |
| MX (1) | MX2007005474A (zh) |
| PL (1) | PL1814907T3 (zh) |
| PT (1) | PT1814907E (zh) |
| WO (1) | WO2006048768A2 (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2136631B1 (en) * | 2007-04-14 | 2012-08-15 | Southern Research Institute | Methods for treating neoplasia with combination of chemotherapeutic agents and radiation |
| US9687515B2 (en) | 2007-11-19 | 2017-06-27 | Transgene S.A. | Poxviral oncolytic vectors |
| SG178254A1 (en) | 2009-08-07 | 2012-03-29 | Transgene Sa | Composition for treating hbv infection |
| TW201221063A (en) * | 2010-12-13 | 2012-06-01 | Tai-Song Guo | Enzyme-assisting yeast, enzyme dough, brewed dough and method of brewing bread, baozi, mantou, bagel and unique enzyme thereof |
| EP3129037B1 (en) | 2014-04-10 | 2019-11-13 | Transgene | Poxviral oncolytic vectors |
| EP3486322B1 (en) * | 2016-07-13 | 2021-09-29 | National University Corporation Tottori University | Method for producing vaccinia virus expressing foreign gene |
| WO2018091680A1 (en) | 2016-11-18 | 2018-05-24 | Transgene Sa | Cowpox-based oncolytic vectors |
| US20200032249A1 (en) * | 2017-03-14 | 2020-01-30 | Memorial Sloan Kettering Cancer Center | Labeling, isolation, & analysis of rna from rare cell populations |
| CN111826393B (zh) * | 2020-08-04 | 2022-02-08 | 湖南农业大学 | 一种同时调控水稻粒型粒重和抗性的基因及其编码蛋白的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5856153A (en) * | 1994-11-17 | 1999-01-05 | Cayla | Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases |
| US5858707A (en) * | 1995-07-05 | 1999-01-12 | Schering Corporation | Purified mammalian nucleobase permeases; nucleic acids; antibodies |
| US6153740A (en) * | 1995-07-07 | 2000-11-28 | University Of Alberta | cDNA encoding nucleoside transporter |
| US6749863B1 (en) * | 1997-11-19 | 2004-06-15 | Georgetown University | Targeted liposome gene delivery |
| FR2777570A1 (fr) * | 1998-04-17 | 1999-10-22 | Transgene Sa | Mutant ayant une activite phosphoribosyl transferase |
| US6552005B1 (en) * | 1998-09-29 | 2003-04-22 | Uab Research Foundation | Molecular chemotherapy enhancement of radiotherapy |
| FR2794025A1 (fr) * | 1999-05-25 | 2000-12-01 | Transgene Sa | Composition destinee a la mise en oeuvre d'un traitement antitumoral ou antiviral chez un mammifere |
-
2005
- 2005-10-26 MX MX2007005474A patent/MX2007005474A/es active IP Right Grant
- 2005-10-26 EP EP05802308A patent/EP1814907B1/en not_active Not-in-force
- 2005-10-26 PL PL05802308T patent/PL1814907T3/pl unknown
- 2005-10-26 ES ES05802308T patent/ES2320157T3/es active Active
- 2005-10-26 US US11/667,254 patent/US8470591B2/en not_active Expired - Fee Related
- 2005-10-26 DK DK05802308T patent/DK1814907T3/da active
- 2005-10-26 JP JP2007539650A patent/JP5372374B2/ja not_active Expired - Fee Related
- 2005-10-26 DE DE602005012535T patent/DE602005012535D1/de active Active
- 2005-10-26 KR KR1020077012977A patent/KR101134185B1/ko not_active IP Right Cessation
- 2005-10-26 AT AT05802308T patent/ATE421534T1/de active
- 2005-10-26 CA CA2584681A patent/CA2584681C/en not_active Expired - Fee Related
- 2005-10-26 HK HK08101248.0A patent/HK1107360A1/xx not_active IP Right Cessation
- 2005-10-26 AU AU2005300248A patent/AU2005300248B2/en not_active Ceased
- 2005-10-26 WO PCT/IB2005/003435 patent/WO2006048768A2/en active Application Filing
- 2005-10-26 CN CN2005800376771A patent/CN101072792B/zh not_active Expired - Fee Related
- 2005-11-14 PT PT05802308T patent/PT1814907E/pt unknown
-
2007
- 2007-05-06 IL IL183015A patent/IL183015A/en not_active IP Right Cessation
-
2009
- 2009-04-15 CY CY20091100450T patent/CY1109850T1/el unknown
-
2013
- 2013-06-05 JP JP2013119206A patent/JP2013209415A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1814907A2 (en) | 2007-08-08 |
| EP1814907B1 (en) | 2009-01-21 |
| CA2584681A1 (en) | 2006-05-11 |
| JP5372374B2 (ja) | 2013-12-18 |
| MX2007005474A (es) | 2007-07-10 |
| CN101072792A (zh) | 2007-11-14 |
| WO2006048768A8 (en) | 2007-06-14 |
| DK1814907T3 (da) | 2009-05-18 |
| ES2320157T3 (es) | 2009-05-19 |
| JP2008519024A (ja) | 2008-06-05 |
| KR101134185B1 (ko) | 2012-04-09 |
| KR20070091614A (ko) | 2007-09-11 |
| IL183015A (en) | 2012-02-29 |
| AU2005300248A1 (en) | 2006-05-11 |
| CA2584681C (en) | 2014-05-13 |
| JP2013209415A (ja) | 2013-10-10 |
| PT1814907E (pt) | 2009-03-27 |
| WO2006048768A2 (en) | 2006-05-11 |
| CN101072792B (zh) | 2012-09-26 |
| IL183015A0 (en) | 2007-09-20 |
| ATE421534T1 (de) | 2009-02-15 |
| CY1109850T1 (el) | 2014-09-10 |
| US8470591B2 (en) | 2013-06-25 |
| DE602005012535D1 (de) | 2009-03-12 |
| WO2006048768A3 (en) | 2006-08-03 |
| US20090170795A1 (en) | 2009-07-02 |
| PL1814907T3 (pl) | 2009-07-31 |
| AU2005300248B2 (en) | 2012-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL183015A0 (en) | Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal | |
| JO3076B1 (ar) | نظم العلاج المناعي المعتمد على حالة apoe | |
| TW200700433A (en) | Acylated glp-1 compounds | |
| UA93653C2 (ru) | Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r) | |
| MX2007009807A (es) | Agentes terapeuticos de aptameros utiles en el tratamiento de trastornos relacionados con el complemento. | |
| TW200611910A (en) | Interferon-alpha polypeptides and conjugates | |
| IL189555A0 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
| UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
| SG156690A1 (en) | Mammalian genes involved in infection | |
| PH12014500829A1 (en) | Mutations in oas1 genes | |
| IL174787A0 (en) | Use of cell lines to produce active therapeutic proteins | |
| UA86399C2 (ru) | Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза | |
| TW200724679A (en) | Treatment of disease using an improved regulated expression system | |
| WO2008148932A3 (en) | Glycosylasparaginase for treatment of cancers or inflammatory diseases | |
| PL2046394T3 (pl) | Zastosowanie sekwencji kwasów nukleinowych do leczenia chorób neurologicznych i psychiatrycznych, wektory i kompozycje | |
| IL174645A0 (en) | MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES | |
| UA93658C2 (en) | Cell surface glycoprotein | |
| EP1828237A4 (en) | HUMAN CANCER SUPPRESSOR GENE, PROTEIN ENCODED THEREIN, EXPRESSION VECTOR CONTAINING THE GENE, AND CELL TRANSFORMED BY THE VECTOR | |
| WO2006043060A3 (en) | Mam domain containing protein | |
| SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
| IL169256A0 (en) | Metalloprotease proteins | |
| TW200716749A (en) | Interferon-beta gene therapy using an improved, regulated expression system | |
| GB2489180A (en) | Method of predicting capecitabine toxicity | |
| EP1838727A4 (en) | HUMAN CANCER SUPPRESSION GENES, THE PROTEIN CODED THEREIN AND THE EXPRESSION VECTOR CONTAINING THEREOF | |
| WO2006051333A3 (en) | Leucine-rich repeat (lrr) motif containing proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S146 | Correction of errors in patents and applications under section 146 of the patents ordinance |
Free format text: CORRECTION OF THE EP APPLICATION FILING DATE FROM 14.11.2005 TO 26.10.2005 Effective date: 20081030 |
|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20181024 |